Related Experiment Video
Updated: Sep 6, 2026
Development of a Unilaterally-lesioned 6-OHDA Mouse Model of Parkinson's Disease
Published on: February 14, 2012
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice
Abstract:
The effects of different dosing paradigms for the administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were investigated in C57-black and CF-W albino mice. Several groups of mice received a total dose of 80 mg/kg of MPTP administered at different doses per injection and/or at different time intervals. In C57-black mice, the effects of MPTP administration on the neostriatal content of dopamine ranged from a 91% depletion (4 injections of 20 mg/kg per injection at 1 h intervals) to a non-significant effect (4 injections of 10 mg/kg per injection at 2 h intervals on each of 2 successive days). There was also considerable influence of the MPTP dose per injection and the dosing interval in CF-W mice, although the extent of neostriatal dopamine depletion in CF-W mice was not as great as that observed in C57-black mice. In addition, MPTP produced variable effects on neostriatal dopamine levels in different strains of mice as well as in Swiss-Webster mice obtained from different sources. Some of the strains were affected to a great extent while others were only marginally affected.
Insights
MPTP dosing significantly impacts dopamine levels in mice, with C57-black mice showing greater depletion. Dosing paradigms and mouse strain variability influence neurotoxic effects.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin known to cause dopamine depletion.
- Understanding MPTP's effects is crucial for Parkinson's disease research.
Purpose of the Study:
- To investigate how different dosing schedules of MPTP affect dopamine levels in mice.
- To assess the influence of mouse strain and MPTP administration parameters on neurotoxicity.
Main Methods:
- Administered a total dose of 80 mg/kg MPTP to C57-black and CF-W albino mice.
- Varied MPTP dose per injection and time intervals between injections.
- Measured neostriatal dopamine content.
Main Results:
- MPTP administration caused significant dopamine depletion in C57-black mice, up to 91%.
- Dosing paradigms (dose/injection, interval) and mouse strain influenced dopamine depletion.
- CF-W mice showed less dopamine depletion than C57-black mice.
- Variability in MPTP effects was observed across different mouse strains and sources.
Conclusions:
- MPTP neurotoxicity is highly dependent on the dosing regimen and the genetic background of the mice.
- Dosing strategies can modulate the extent of dopamine depletion caused by MPTP.
- Strain-specific responses highlight the complexity of MPTP-induced neurodegeneration.
